Drug Profile
AQ 401
Alternative Names: AQ401Latest Information Update: 28 Aug 2018
Price :
$50
*
At a glance
- Originator Aqua Pharmaceuticals
- Class Antiacnes
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Acne
Most Recent Events
- 28 Aug 2018 No recent reports of development identified for phase-I development in Acne in USA
- 24 Jul 2015 Phase-I clinical trials in Acne in USA (unspecified route)